Plasma Levels of the Gut Bacteria‐Derived Metabolite Imidazole Propionate Are Negatively Associated with Cognitive Scores

Abstract

Background: Among the various modifiable risk factors for AD development, the gut microbiome stands out as a potential therapeutic target, offering opportunities for intervention in the very early stages to potentially prevent disease onset.